Interventions to address stimulant and opioid use that consider race and gender may prove more effective at preventing overdose deaths than current methods, according to a Penn State-led team of researchers who studied how drug treatment admissions and overdose deaths differed among race and gender.
A VC-backed genetic testing startup to ‘consider’ making an offer to buy 23andMe
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS